OBJECTIVE: A proapoptotic BH3-only protein BIM (BCL-2 interacting mediator of cell death) can link cytokine receptor signaling with the apoptotic machinery in hematopoietic cells. We investigated here the role of BIM in erythropoietin (EPO)-mediated survival in erythroid cells. MATERIALS AND METHODS: We downregulated BIM in EPO-dependent HCD57 erythroid cells with short hairpin RNA (shRNA), and used real-time polymerase chain reaction, Western blots, and flow cytometry to characterize BIM expression and apoptosis. Hematologic analyses of BIM-deficient (Bim(-/-)) mice were conducted. RESULTS: BIM expression increases in primary murine erythroid cells and HCD57 cells deprived of EPO. Whereas Bim mRNA increased less than twofold, BIM protein increased more than 10-fold after EPO withdrawal, suggesting posttranscriptional regulation of BIM. EPO treatment resulted in rapid phosphorylation of BIM at Serine 65 and phosphorylation correlated with degradation of BIM. Inhibition of extracellular signal-regulated kinase (ERK) by a MEK/ERK inhibitor, U0126, blocked both phosphorylation and degradation of BIM, resulting in apoptosis. Treatment with a proteasome inhibitor, MG-132, also blocked degradation of phosphorylated BIM. Downregulation of BIM with the shRNA resulted in HCD57 cells more resistant to apoptosis induced by either EPO withdrawal or ERK inhibition. Although we observed no significant changes in the number of erythrocytes or reticulocytes in the circulation of Bim(-/-) mice, erythroid progenitors from bone marrow in Bim(-/-) mice were reduced in number and more resistant to apoptosis induced by U0126 MEK/ERK inhibitor. CONCLUSION: EPO protects erythroid cells from apoptosis in part through ERK-mediated phosphorylation followed by proteasomal degradation of BIM.
OBJECTIVE: A proapoptotic BH3-only protein BIM (BCL-2 interacting mediator of cell death) can link cytokine receptor signaling with the apoptotic machinery in hematopoietic cells. We investigated here the role of BIM in erythropoietin (EPO)-mediated survival in erythroid cells. MATERIALS AND METHODS: We downregulated BIM in EPO-dependent HCD57 erythroid cells with short hairpin RNA (shRNA), and used real-time polymerase chain reaction, Western blots, and flow cytometry to characterize BIM expression and apoptosis. Hematologic analyses of BIM-deficient (Bim(-/-)) mice were conducted. RESULTS:BIM expression increases in primary murine erythroid cells and HCD57 cells deprived of EPO. Whereas Bim mRNA increased less than twofold, BIM protein increased more than 10-fold after EPO withdrawal, suggesting posttranscriptional regulation of BIM. EPO treatment resulted in rapid phosphorylation of BIM at Serine 65 and phosphorylation correlated with degradation of BIM. Inhibition of extracellular signal-regulated kinase (ERK) by a MEK/ERK inhibitor, U0126, blocked both phosphorylation and degradation of BIM, resulting in apoptosis. Treatment with a proteasome inhibitor, MG-132, also blocked degradation of phosphorylated BIM. Downregulation of BIM with the shRNA resulted in HCD57 cells more resistant to apoptosis induced by either EPO withdrawal or ERK inhibition. Although we observed no significant changes in the number of erythrocytes or reticulocytes in the circulation of Bim(-/-) mice, erythroid progenitors from bone marrow in Bim(-/-) mice were reduced in number and more resistant to apoptosis induced by U0126MEK/ERK inhibitor. CONCLUSION:EPO protects erythroid cells from apoptosis in part through ERK-mediated phosphorylation followed by proteasomal degradation of BIM.
Authors: P Bouillet; D Metcalf; D C Huang; D M Tarlinton; T W Kay; F Köntgen; J M Adams; A Strasser Journal: Science Date: 1999-11-26 Impact factor: 47.728
Authors: Rachel L Schweers; Ji Zhang; Mindy S Randall; Melanie R Loyd; Weimin Li; Frank C Dorsey; Mondira Kundu; Joseph T Opferman; John L Cleveland; Jeffery L Miller; Paul A Ney Journal: Proc Natl Acad Sci U S A Date: 2007-11-29 Impact factor: 11.205
Authors: Hector Sandoval; Perumal Thiagarajan; Swapan K Dasgupta; Armin Schumacher; Josef T Prchal; Min Chen; Jin Wang Journal: Nature Date: 2008-05-04 Impact factor: 49.962
Authors: Abhinav Diwan; Andrew G Koesters; Amy M Odley; Suvarnamala Pushkaran; Christopher P Baines; Benjamin T Spike; Diedre Daria; Anil G Jegga; Hartmut Geiger; Bruce J Aronow; Jeffery D Molkentin; Kay F Macleod; Theodosia A Kalfa; Gerald W Dorn Journal: Proc Natl Acad Sci U S A Date: 2007-04-09 Impact factor: 11.205
Authors: Pascale F Dijkers; Kim U Birkenkamp; Eric W-F Lam; N Shaun B Thomas; Jan-Willem J Lammers; Leo Koenderman; Paul J Coffer Journal: J Cell Biol Date: 2002-01-28 Impact factor: 10.539
Authors: Miroslav Koulnis; Ermelinda Porpiglia; P Alberto Porpiglia; Ying Liu; Kelly Hallstrom; Daniel Hidalgo; Merav Socolovsky Journal: Blood Date: 2011-11-15 Impact factor: 22.113
Authors: M Ridinger-Saison; E Evanno; I Gallais; P Rimmelé; D Selimoglu-Buet; E Sapharikas; F Moreau-Gachelin; C Guillouf Journal: Cell Death Differ Date: 2013-07-12 Impact factor: 15.828
Authors: Britta Will; Tanya Siddiqi; Meritxell Alberich Jordà; Takeshi Shimamura; Katarina Luptakova; Philipp B Staber; Daniel B Costa; Ulrich Steidl; Daniel G Tenen; Susumu Kobayashi Journal: Blood Date: 2010-02-16 Impact factor: 22.113